“Abbott leads the global market with over 25% share due to its expansive POC portfolio,” said Elder. “Dexcom and Roche are advancing CGM and coagulation testing, while Exact Sciences is driving growth ...

If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your ...